News Roundup: January 2 to January 6
Your weekly roundup of the latest news from Drug Topics®.
How to Prioritize Tamiflu in Cases of Shortage
Reports of localized supply issues with Tamiflu have left some providers wondering how to best prioritize who gets the antiviral during a rough flu season.
FDA Allows Dispensing of Mifepristone in Retail Pharmacies
Following certification, brick-and-mortar pharmacies will be able to provide the medication to patients.
Flu Shot Reduced Outpatient Care Needed in 2021-2022 Flu Season
Research on last season’s influenza vaccine efficacy bodes well for patients who have gotten their flu shot this season.
Federal Guideline Changes Reduce HIV Prescribing Disparities
Researchers speculate that the disparities among those with private insurance coverage may reflect differences in overcoming hurdles to access, such as prior authorization.
Convenience an Important Factor in the Multiple Myeloma Treatment Equation
The COVID-19 pandemic revealed the advantages of treatment that involved fewer in-person office visits, according to recent research.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
